Effect of otilonium bromide on contractile patterns in the human sigmoid colon

Neurogastroenterology and Motility

Volumn 22, Issue 6, 2010, Pages

  Gallego, D ^a   Auli M ^b,c   Aleu, J ^b   Martinez E ^b,c   Rofes, L ^a   Marti Rague J ^b   Jimenez M ^a,b   Clave P ^a,b,c  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Fundacio de Gastroenterologia Dr F Vilardell   (Spain)

Author keywords

Gastrointestinal motility; Sigmoid colon; Smooth muscle; Spasmolytic drugs

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; ACETYLCHOLINE; ATROPINE; BENZOYLALANYLALANYL DEXTRO TRYPTOPHYLPHENYLALANYL DEXTRO PROLYLPROLYLNORLEUCINAMIDE; CALCIUM; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL STIMULATING AGENT; HEXAMETHONIUM; NEUROKININ 2 RECEPTOR ANTAGONIST; NEUROKININ A; NIFEDIPINE; OTILONIUM BROMIDE; SUBSTANCE P; THAPSIGARGIN;

ADULT; ARTICLE; CALCIUM TRANSPORT; COLON MOTILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROSTIMULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IC 50; IN VITRO STUDY; LATENT PERIOD; MALE; MOTONEURON; MUSCLE STRETCHING; PRIORITY JOURNAL; SIGMOID; SMOOTH MUSCLE FIBER;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; COLON, SIGMOID; ELECTRIC STIMULATION; GASTROINTESTINAL MOTILITY; HUMANS; ISOMETRIC CONTRACTION; MIDDLE AGED; MOTOR NEURONS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NEUROTRANSMITTER AGENTS; PARASYMPATHOLYTICS; PHYSICAL STIMULATION; QUATERNARY AMMONIUM COMPOUNDS; REFLEX, STRETCH;

EID: 77951956957     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2010.01495.x     Document Type: Article

References (31)

1. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: An international survey of 40,000 subjects. Aliment Pharmacol Ther 2003 17 : 643 650. (Pubitemid 36418887)
2. Ford AC, Talley NJ, Spiegel BM et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ 2008 337 : A2313.
3. Kanazawa M, Palsson OS, Thiwan SI et al. Contributions of pain sensitivity and colonic motility to IBS symptom severity and predominant bowel habits. Am J Gastroenterol 2008 103 : 2550 2561.
4. Jailwala J, Imperiale TF, Kroenke K. Pharmacologic treatment of the irritable bowel syndrome: A systematic review of randomized, controlled trials. Ann Intern Med 2000 133 : 136 147. (Pubitemid 30490414)
5. Spinelli A. Irritable bowel syndrome. Clin Drug Investig 2007 27 : 15 33. (Pubitemid 46058732)
6. Baldi F, Longanesi A, Blasi A et al. Clinical and functional evaluation of the efficacy of otilonium bromide: A multicenter study in Italy. Ital J Gastroenterol 1991 23 : 60 3.
7. Baldi F, Longanesi A, Blasi A et al. Octylonium bromide in the treatment of the irritable bowel syndrome: A clinical-functional study 1. Hepatogastroenterology 1992 39 : 392 395.
8. Battaglia G, Morselli-Labate AM, Camarri E et al. Otilonium bromide in irritable bowel syndrome: A double-blind, placebo-controlled, 15-week study 4. Aliment Pharmacol Ther 1998 12 : 1003 1010. (Pubitemid 28454384)
9. Tack J, Fried M, Houghton LA, Spicak J, Fisher G. Systematic review: the efficacy of treatments for irritable bowel syndrome - a European perspective 17. Aliment Pharmacol Ther 2006 24 : 183 205. (Pubitemid 43972890)
10. Evangelista S. Quaternary ammonium derivatives as spasmolytics for irritable bowel syndrome. Curr Pharm Des 2004 10 : 3561 3568. (Pubitemid 39378335)
11. Gandia L, Villarroya M, Lara B et al. Otilonium: A potent blocker of neuronal nicotinic ACh receptors in bovine chromaffin cells 25. Br J Pharmacol 1996 117 : 463 470. (Pubitemid 26056856)
12. Evangelista S, Giachetti A, Chapelain B, Neliat G, Maggi CA. Receptor binding profile of otilonium bromide 20. Pharmacol Res 1998 38 : 111 117. (Pubitemid 28349887)
13. Auli M, Martinez E, Gallego D et al. Effects of excitatory and inhibitory neurotransmission on motor patterns of human sigmoid colon in vitro. Br J Pharmacol 2008 155 : 1043 1055.
14. Gallego D, Gil V, Aleu J, Auli M, Clave P, Jimenez M. Purinergic and nitrergic junction potential in the human colon. Am J Physiol Gastrointest Liver Physiol 2008 295 : G522 33.
15. Lindqvist S, Hernon J, Sharp P et al. The colon-selective spasmolytic otilonium bromide inhibits muscarinic M(3) receptor-coupled calcium signals in isolated human colonic crypts 1. Br J Pharmacol 2002 137 : 1134 1142. (Pubitemid 35440754)
16. Farrugia G, Holm AN, Rich A, Sarr MG, Szurszewski JH, Rae JL. A mechanosensitive calcium channel in human intestinal smooth muscle cells 1. Gastroenterology 1999 117 : 900 905. (Pubitemid 29468233)
17. Martin MT, Hove-Madsen L, Jimenez M. Otilonium bromide inhibits muscle contractions via L-type calcium channels in the rat colon 5. Neurogastroenterol Motil 2004 16 : 175 183. (Pubitemid 38580962)
18. Strege PR, Evangelista S, Lyford GL, Sarr MG, Farrugia G. Otilonium bromide inhibits calcium entry through L-type calcium channels in human intestinal smooth muscle 6. Neurogastroenterol Motil 2004 16 : 167 173. (Pubitemid 38580961)
19. Sutton JA, Kilminster SG, Mould GP. The clinical pharmacology of single doses of otilonium bromide in healthy volunteers. Eur J Clin Pharmacol 1997 52 : 365 369. (Pubitemid 27341936)
20. Shin BS, Kim JJ, Kim J et al. Oral bioavailability and enterohepatic recirculation of otilonium bromide in rats. Arch Pharm Res 2008 31 : 117 124.
21. Amenta F, Baroldi P, Ferrante F, Napoleone P, Meli A. Autoradiographic localization of octylonium bromide binding sites in the rat gastrointestinal tract 17. Arch Int Pharmacodyn Ther 1991 311 : 5 19.
22. Evangelista S, Cochet P, Bromet N, Criscuoli M, Maggi CA. A distribution study with (14)C-otilonium bromide in the rat: Evidence for selective tropism for large intestine after oral administration. Drug Metab Dispos 2000 28 : 643 647. (Pubitemid 30390402)
23. Malysz J, Richardson D, Farraway L, Christen MO, Huizinga JD. Generation of slow wave type action potentials in the mouse small intestine involves a non-L-type calcium channel. Can J Physiol Pharmacol 1995 73 : 1502 1511. (Pubitemid 26025563)
24. Santicioli P, Zagorodnyuk V, Renzetti AR, Maggi CA. Antimuscarinic, calcium channel blocker and tachykinin NK2 receptor antagonist actions of otilonium bromide in the circular muscle of guinea-pig colon. Naunyn Schmiedebergs Arch Pharmacol 1999 359 : 420 427. (Pubitemid 29252284)
25. Striessnig J, Grabner M, Mitterdorfer J, Hering S, Sinnegger MJ, Glossmann H. Structural basis of drug binding to L Ca2 + channels. Trends Pharmacol Sci 1998 19 : 108 115. (Pubitemid 28197812)
26. Lyford GL, Strege PR, Shepard A et al. alpha(1C) (Ca(V)1.2) L-type calcium channel mediates mechanosensitive calcium regulation. Am J Physiol Cell Physiol 2002 283 : C1001 8. (Pubitemid 34920332)
27. Sato K, Sanders KM, Gerthoffer WT, Publicover NG. Sources of calcium utilized in cholinergic responses in canine colonic smooth muscle. Am J Physiol 1994 267 : C1666 73.
28. Cao W, Pricolo VE, Zhang L, Behar J, Biancani P, Kirber MT. Gq-linked NK(2) receptors mediate neurally induced contraction of human sigmoid circular smooth muscle. Gastroenterology 2000 119 : 51 61. (Pubitemid 30452578)
29. Sarna SK. Molecular, functional, and pharmacological targets for the development of gut promotility drugs. Am J Physiol Gastrointest Liver Physiol 2006 291 : G545 55.
30. Huizinga JD, Stern HS, Chow E, Diamant NE, el-Sharkawy TY. Electrophysiologic control of motility in the human colon. Gastroenterology 1985 88 : 500 511. (Pubitemid 15194716)
31. Rao SS, Sadeghi P, Beaty J, Kavlock R, Ackerson K. Ambulatory 24-h colonic manometry in healthy humans. Am J Physiol Gastrointest Liver Physiol 2001 280 : G629 39. (Pubitemid 32472356)